These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32861031)

  • 21. Microfluidic modelling of the tumor microenvironment for anti-cancer drug development.
    Shang M; Soon RH; Lim CT; Khoo BL; Han J
    Lab Chip; 2019 Jan; 19(3):369-386. PubMed ID: 30644496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Migration and Proliferation Potential of the Hydrogel Aided 3D Tumoroid.
    Modi U; Kedaria D; Vasita R
    Macromol Biosci; 2022 Nov; 22(11):e2200196. PubMed ID: 35997309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-Dimensional Microfluidic Tri-Culture Model of the Bone Marrow Microenvironment for Study of Acute Lymphoblastic Leukemia.
    Bruce A; Evans R; Mezan R; Shi L; Moses BS; Martin KH; Gibson LF; Yang Y
    PLoS One; 2015; 10(10):e0140506. PubMed ID: 26488876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional profiling of triple-negative breast cancer patient-derived tumoroids for disease modeling.
    Cromwell EF; Sirenko O; Nikolov E; Hammer M; Brock CK; Matossian MD; Alzoubi MS; Collins-Burow BM; Burow ME
    SLAS Discov; 2022 Apr; 27(3):191-200. PubMed ID: 35124274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial-to-Mesenchymal Transition (EMT) and Drug Response in Dynamic Bioengineered Lung Cancer Microenvironment.
    Mani V; Lyu Z; Kumar V; Ercal B; Chen H; Malhotra SV; Demirci U
    Adv Biosyst; 2019 Jan; 3(1):e1800223. PubMed ID: 32627339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids.
    Schuster B; Junkin M; Kashaf SS; Romero-Calvo I; Kirby K; Matthews J; Weber CR; Rzhetsky A; White KP; Tay S
    Nat Commun; 2020 Oct; 11(1):5271. PubMed ID: 33077832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KRAS mutations in the parental tumour accelerate in vitro growth of tumoroids established from colorectal adenocarcinoma.
    Mousavi N; Truelsen SLB; Hagel G; Jorgensen LN; Harling H; Timmermans V; Melchior LC; Thysen AH; Heegaard S; Thastrup J
    Int J Exp Pathol; 2019 Feb; 100(1):12-18. PubMed ID: 30884019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical Characterization of Colorectal Cancer Spheroids and Evaluation of NK Cell Infiltration Through a Flow-Based Analysis.
    Sargenti A; Musmeci F; Bacchi F; Delprete C; Cristaldi DA; Cannas F; Bonetti S; Pasqua S; Gazzola D; Costa D; Villa F; Zocchi MR; Poggi A
    Front Immunol; 2020; 11():564887. PubMed ID: 33424829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A microfluidic platform for drug screening in a 3D cancer microenvironment.
    Pandya HJ; Dhingra K; Prabhakar D; Chandrasekar V; Natarajan SK; Vasan AS; Kulkarni A; Shafiee H
    Biosens Bioelectron; 2017 Aug; 94():632-642. PubMed ID: 28371753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform.
    Lanz HL; Saleh A; Kramer B; Cairns J; Ng CP; Yu J; Trietsch SJ; Hankemeier T; Joore J; Vulto P; Weinshilboum R; Wang L
    BMC Cancer; 2017 Nov; 17(1):709. PubMed ID: 29096610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance.
    Lee JH; Kim SK; Khawar IA; Jeong SY; Chung S; Kuh HJ
    J Exp Clin Cancer Res; 2018 Jan; 37(1):4. PubMed ID: 29329547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Microfluidic Spheroid Culture Device with a Concentration Gradient Generator for High-Throughput Screening of Drug Efficacy.
    Lim W; Park S
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30567363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform.
    Xing F; Liu YC; Huang S; Lyu X; Su SM; Chan UI; Wu PC; Yan Y; Ai N; Li J; Zhao M; Rajendran BK; Liu J; Shao F; Sun H; Choi TK; Zhu W; Luo G; Liu S; Xu L; Chan KL; Zhao Q; Miao K; Luo KQ; Ge W; Xu X; Wang G; Liu TM; Deng CX
    Theranostics; 2021; 11(19):9415-9430. PubMed ID: 34646378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.
    Amirghasemi F; Adjei-Sowah E; Pockaj BA; Nikkhah M
    Ann Biomed Eng; 2021 Aug; 49(8):1943-1972. PubMed ID: 33403451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three dimensional microfluidic cell arrays for ex vivo drug screening with mimicked vascular flow.
    Dereli-Korkut Z; Akaydin HD; Ahmed AH; Jiang X; Wang S
    Anal Chem; 2014 Mar; 86(6):2997-3004. PubMed ID: 24568664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment.
    Bai J; Tu TY; Kim C; Thiery JP; Kamm RD
    Oncotarget; 2015 Nov; 6(34):36603-14. PubMed ID: 26474384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A microfluidics platform for combinatorial drug screening on cancer biopsies.
    Eduati F; Utharala R; Madhavan D; Neumann UP; Longerich T; Cramer T; Saez-Rodriguez J; Merten CA
    Nat Commun; 2018 Jun; 9(1):2434. PubMed ID: 29934552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascularization of Patient-Derived Tumoroid from Non-Small-Cell Lung Cancer and Its Microenvironment.
    Seitlinger J; Nounsi A; Idoux-Gillet Y; Santos Pujol E; Lê H; Grandgirard E; Olland A; Lindner V; Zaupa C; Balloul JM; Quemeneur E; Massard G; Falcoz PE; Hua G; Benkirane-Jessel N
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiparkinson Drug Benztropine Suppresses Tumor Growth, Circulating Tumor Cells, and Metastasis by Acting on SLC6A3/DAT and Reducing STAT3.
    Sogawa C; Eguchi T; Tran MT; Ishige M; Trin K; Okusha Y; Taha EA; Lu Y; Kawai H; Sogawa N; Takigawa M; Calderwood SK; Okamoto K; Kozaki KI
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32102440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a Colorectal Cancer 3D Micro-tumor Construct Platform From Cell Lines and Patient Tumor Biospecimens for Standard-of-Care and Experimental Drug Screening.
    Forsythe S; Mehta N; Devarasetty M; Sivakumar H; Gmeiner W; Soker S; Votanopoulos K; Skardal A
    Ann Biomed Eng; 2020 Mar; 48(3):940-952. PubMed ID: 31020445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.